We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock
GRNA

Delisted

GRNA was delisted on the 21st of July, 2023.

Back to rankings

32 hedge funds and large institutions have $95.9M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2021 Q1 according to their latest regulatory filings, with 32 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
32
Holders Change
+32
Holders Change %
–
% of All Funds
0.56%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
32
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
+$40.3M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$18.2M
3
HCM
Highbridge Capital Management
New York
+$6.11M
4
TAM
Telemark Asset Management
Massachusetts
+$5.89M
5
UOC
UBS O'Connor
Illinois
+$5.88M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Adage Capital Partners
1
Adage Capital Partners
Massachusetts
$17.9M +$18.2M +1,850,000 New
Hudson Bay Capital Management
2
Hudson Bay Capital Management
Connecticut
$12.8M +$40.3M +4,105,000 New
HCM
3
Highbridge Capital Management
New York
$6.03M +$6.11M +622,330 New
TAM
4
Telemark Asset Management
Massachusetts
$5.81M +$5.89M +600,000 New
UOC
5
UBS O'Connor
Illinois
$5.81M +$5.88M +599,586 New
CH
6
CVI Holdings
Delaware
$4.84M +$4.91M +500,000 New
PAMP
7
Polar Asset Management Partners
Ontario, Canada
$4.6M +$4.66M +475,000 New
MWNA
8
Marshall Wace North America
New York
$4.44M +$4.5M +458,576 New
Balyasny Asset Management
9
Balyasny Asset Management
Illinois
$3.88M +$3.92M +400,000 New
FTCM
10
Fir Tree Capital Management
New York
$3.39M +$3.43M +350,000 New
CAC
11
Cowen and Company
New York
$2.91M +$2.94M +300,000 New
CIM
12
Cowen Investment Management
New York
$2.42M +$2.45M +250,000 New
SCM
13
Saba Capital Management
New York
$2.37M +$2.4M +244,835 New
CCA
14
Castle Creek Arbitrage
Colorado
$1.94M +$1.96M +200,000 New
HIM
15
HGC Investment Management
Ontario, Canada
$1.94M +$1.96M +200,000 New
MI
16
MMCAP International
Cayman Islands
$1.94M +$1.96M +200,000 New
BCM
17
Basso Capital Management
Connecticut
$1.91M +$1.94M +197,438 New
WA
18
Whitebox Advisors
Minnesota
$1.71M +$1.73M +176,019 New
TCM
19
Tenor Capital Management
New York
$1.45M +$1.47M +150,000 New
Goldman Sachs
20
Goldman Sachs
New York
$1.33M +$1.35M +137,400 New
AFM
21
Anson Funds Management
Texas
$1.21M +$1.23M +125,000 New
NM
22
Newtyn Management
New York
$1.21M +$1.23M +125,000 New
VI
23
Vestcor Inc
New Brunswick, Canada
$1.09M +$1.1M +112,500 New
Nomura Holdings
24
Nomura Holdings
Japan
$772K +$782K +79,659 New
CL
25
CSS LLC
Illinois
$753K +$763K +77,741 New
1
2

GRNA Hedge Fund Activity: Q1 2021 in Review

32 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q1 2021, worth a combined $95.9M.

Buyers outnumbered sellers: 32 funds opened new GRNA positions and 0 closed out — a net gain of 32 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $40.3M.

  • 32 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $95.9M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q1 2021.
  • 32 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q1 2021 and 0 closed out, a net change of +32 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q1 2021 was Hudson Bay Capital Management, an estimated $40.3M added.

Based on aggregated 13F filings for Q1 2021.